Enfermedad hepatobiliar asociada a COVID-19
DOI:
https://doi.org/10.52784/27112330.155Palabras clave:
COVID-19, SARS-CoV-2, hígado, hepatopatías, vacunas.Resumen
La enfermedad COVID-19, causada por el coronavirus tipo 2 (SARS-CoV-2), ha tenido un gran impacto en la salud a nivel mundial. A pesar de considerarse una enfermedad principalmente respiratoria, el virus SARS-CoV-2 también es responsable de otro tipo de manifestaciones extrapulmonares, como son las enfermedades hepatobiliares. En esta revisión se describen los posibles mecanismos de patogénesis implicados en la lesión hepática causada por el SARS-CoV-2. Adicionalmente, se analiza la relación entre COVID-19 y la enfermedad hepática crónica, las implicaciones que tiene en el carcinoma hepatocelular y en el trasplante hepático, así como las recomendaciones para la vacunación contra el SARS-CoV-2 en los pacientes afectados por enfermedad hepática. Por último, se proponen algunas estrategias para superar el reto al que se enfrenta el médico en el manejo de los pacientes con enfermedades hepatobiliares y COVID-19.
Descargas
Referencias bibliográficas
Chen AT, Wang CY, Zhu WL, Chen W. Coagulation disorders and thrombosis in COVID-19 patients and a possible mechanism involving endothelial cells: A review. Aging Dis 2022;13:144-156. https://doi.org/10.14336/ad.2021.0704.
Al-Saadi E, Abdulnabi MA. Hematological changes associated with COVID-19 infection. J Clin Lab Anal 2022;36:e24064. https://doi.org/10.1002/jcla.24064.
Forero-Saldarriaga S, Puerta-Rojas JD, Estupiñán-Paredes RN, Coy-Pedraza LC, Moreno-Ruiz NL, Castellanos-Parada J. Infección por SARS-CoV-2 y miocarditis. Med Lab 2022;26:35-46. https://doi.org/10.36384/01232576.558.
The Task Force for the management of COVID-19 of the European Society of Cardiology. European Society of Cardiology guidance for the diagnosis and management of cardiovascular disease during the COVID-19 pandemic: part 1-Epidemiology, pathophysiology, and diagnosis. European Heart Journal 2021;43:1033-1058. https://doi.org/10.1093/eurheartj/ehab696.
Task Force for the management of COVID-19 of the European Society of Cardiology. ESC guidance for the diagnosis and management of cardiovascular disease during the COVID-19 pandemic: part 2-care pathways, treatment, and follow-up. Eur Heart J 2022;43:1059-1103. https://doi.org/10.1093/eurheartj/ehab697.
Chen F, Dai Z, Huang C, Chen H, Wang X, Li X. Gastrointestinal disease and COVID-19: A review of current evidence. Dig Dis 2021:1-9. https://doi.org/10.1159/000519412.
Hunt RH, East JE, Lanas A, Malfertheiner P, Satsangi J, Scarpignato C, et al. COVID-19 and gastrointestinal disease: Implications for the gastroenterologist. Dig Dis 2021;39:119-139. https://doi.org/10.1159/000512152.
Ozkurt Z, Çınar-Tanrıverdi E. COVID-19: Gastrointestinal manifestations, liver injury and recommendations. World J Clin Cases 2022;10:1140-1163. https://doi.org/10.12998/wjcc.v10.i4.1140.
Singh J, Malik P, Patel N, Pothuru S, Israni A, Chakinala RC, et al. Kidney disease and COVID-19 disease severity-systematic review and meta-analysis. Clin Exp Med 2022;22:125-135. https://doi.org/10.1007/s10238-021-00715-x.
Jdiaa SS, Mansour R, El Alayli A, Gautam A, Thomas P, Mustafa RA. COVID-19 and chronic kidney disease: an updated overview of reviews. J Nephrol 2022;35:69-85. https://doi.org/10.1007/s40620-021-01206-8.
Hingorani KS, Bhadola S, Cervantes-Arslanian AM. COVID-19 and the brain. Trends Cardiovasc Med 2022. https://doi.org/10.1016/j.tcm.2022.04.004.
Sarubbo F, El Haji K, Vidal-Balle A, Bargay Lleonart J. Neurological consequences of COVID-19 and brain related pathogenic mechanisms: A new challenge for neuroscience. Brain Behav Immun Health 2022;19:100399. https://doi.org/10.1016/j.bbih.2021.100399.
Maiese A, Manetti AC, Bosetti C, Del Duca F, La Russa R, Frati P, et al. SARS-CoV-2 and the brain: A review of the current knowledge on neuropathology in COVID-19. Brain Pathol 2021;31:e13013. https://doi.org/10.1111/bpa.13013.
García-Rueda JE, Caicedo-Bolaños AM, Bermúdez-Flórez AM, Baena-Gallego F, Gómez-Ramírez LA, Correa-Ángel AL, et al. Pitiriasis rosada como manifestación dermatológica de infección por SARS-CoV-2: a propósito de un caso. Med Lab 2022;26:177-186. https://doi.org/10.36384/01232576.575.
Polly S, Fernandez AP. Common skin signs of COVID-19 in adults: An update. Cleve Clin J Med 2022;89:161-167. https://doi.org/10.3949/ccjm.89a.21126.
Seque CA, Enokihara M, Porro AM, Tomimori J. Skin manifestations associated with COVID-19. An Bras Dermatol 2022;97:75-88. https://doi.org/10.1016/j.abd.2021.08.002.
Akl J, El-Kehdy J, Salloum A, Benedetto A, Karam P. Skin disorders associated with the COVID-19 pandemic: A review. J Cosmet Dermatol 2021;20:3105-3115. https://doi.org/10.1111/jocd.14266.
Rao A, Puertolas M, Runde J. COVID-19 and gastrointestinal and hepatobiliary diseases. Pediatr Ann 2021;50:e315-e319. https://doi.org/10.3928/19382359-20210721-02.
Patel KP, Patel PA, Vunnam RR, Hewlett AT, Jain R, Jing R, et al. Gastrointestinal, hepatobiliary, and pancreatic manifestations of COVID-19. J Clin Virol 2020;128:104386. https://doi.org/10.1016/j.jcv.2020.104386.
Idalsoaga F, Ayares G, Arab JP, Díaz LA. COVID-19 and indirect liver injury: A narrative synthesis of the evidence. J Clin Transl Hepatol 2021;9:760-768. https://doi.org/10.14218/jcth.2020.00140.
Mani I, Alexopoulou A. Recent challenges facing patients with preexisting chronic liver disease in the era of the COVID-19 pandemic. Ann Gastroenterol 2021;34:625-633. https://doi.org/10.20524/aog.2021.0628.
Łykowska-Szuber L, Wołodźko K, Rychter AM, Szymczak-Tomczak A, Krela-Kaźmierczak I, Dobrowolska A. Liver injury in patients with coronavirus disease 2019 (COVID-19)-A narrative review. J Clin Med 2021;10. https://doi.org/10.3390/jcm10215048.
Shousha HI, Ramadan A, Lithy R, El-Kassas M. Patterns of liver profile disturbance in patients with COVID-19. World J Clin Cases 2022;10:2063-2071. https://doi.org/10.12998/wjcc.v10.i7.2063.
Kariyawasam JC, Jayarajah U, Abeysuriya V, Riza R, Seneviratne SL. Involvement of the liver in COVID-19: A systematic review. Am J Trop Med Hyg 2022;106:1026-1041. https://doi.org/10.4269/ajtmh.21-1240.
Jothimani D, Venugopal R, Abedin MF, Kaliamoorthy I, Rela M. COVID-19 and the liver. J Hepatol 2020;73:1231-1240. https://doi.org/10.1016/j.jhep.2020.06.006.
Dawood RM, Salum GM, El-Meguid MA. The impact of COVID-19 on liver injury. Am J Med Sci 2022;363:94-103. https://doi.org/10.1016/j.amjms.2021.11.001.
de Sousa-Moreira JL, Barbosa SMB, Gonçalves Júnior J. Pathophysiology and molecular mechanisms of liver injury in severe forms of COVID-19: An integrative review. Clin Res Hepatol Gastroenterol 2021;45:101752. https://doi.org/10.1016/j.clinre.2021.101752.
Díaz-Castrillón FJ, Toro-Montoya AI. SARS-CoV-2/COVID-19: el virus, la enfermedad y la pandemia. Med Lab 2020;24:183-205. https://doi.org/10.36384/01232576.268.
Anirvan P, Narain S, Hajizadeh N, Aloor FZ, Singh SP, Satapathy SK. Cytokine-induced liver injury in coronavirus disease-2019 (COVID-19): untangling the knots. Eur J Gastroenterol Hepatol 2021;33:e42-e49. https://doi.org/10.1097/meg.0000000000002034.
Spearman CW, Aghemo A, Valenti L, Sonderup MW. COVID-19 and the liver: A 2021 update. Liver Int 2021;41:1988-1998. https://doi.org/10.1111/liv.14984.
Wang Y, Liu S, Liu H, Li W, Lin F, Jiang L, et al. SARS-CoV-2 infection of the liver directly contributes to hepatic impairment in patients with COVID-19. J Hepatol 2020;73:807-816. https://doi.org/10.1016/j.jhep.2020.05.002.
Liu C, Yang J, Wang W, Zheng P, Tang Y. Liver injury could be associated with severe disease in COVID-19 patients: a meta-analysis. Eur J Gastroenterol Hepatol 2022;34:237-238. https://doi.org/10.1097/meg.0000000000001953.
Lei F, Liu YM, Zhou F, Qin JJ, Zhang P, Zhu L, et al. Longitudinal association between markers of liver injury and mortality in COVID-19 in China. Hepatology 2020;72:389-398. https://doi.org/10.1002/hep.31301.
Bansal A, Prasad JB. Liver profile in COVID-19: a meta-analysis. Z Gesundh Wiss 2022;30:253-258. https://doi.org/10.1007/s10389-020-01309-9.
Gato S, Lucena-Valera A, Muñoz-Hernández R, Sousa JM, Romero-Gómez M, Ampuero J. Impact of COVID-19 on liver disease: From the experimental to the clinic perspective. World J Virol 2021;10:301-311. https://doi.org/10.5501/wjv.v10.i6.301.
Kariyawasam JC, Jayarajah U, Riza R, Abeysuriya V, Seneviratne SL. Gastrointestinal manifestations in COVID-19. Trans R Soc Trop Med Hyg 2021;115:1362-1388. https://doi.org/10.1093/trstmh/trab042.
Choudhary NS, Dhampalwar S, Saraf N, Soin AS. Outcomes of COVID-19 in patients with cirrhosis or liver transplantation. J Clin Exp Hepatol 2021;11:713-719. https://doi.org/10.1016/j.jceh.2021.05.003.
Ortiz GX, Lenhart G, Becker MW, Schwambach KH, Tovo CV, Blatt CR. Drug-induced liver injury and COVID-19: A review for clinical practice. World J Hepatol 2021;13:1143-1153. https://doi.org/10.4254/wjh.v13.i9.1143.
Wong GL, Wong VW, Thompson A, Jia J, Hou J, Lesmana CRA, et al. Management of patients with liver derangement during the COVID-19 pandemic: an Asia-Pacific position statement. Lancet Gastroenterol Hepatol 2020;5:776-787. https://doi.org/10.1016/s2468-1253(20)30190-4.
Bhurwal A, Minacapelli CD, Orosz E, Gupta K, Tait C, Dalal I, et al. COVID-19 status quo: Emphasis on gastrointestinal and liver manifestations. World J Gastroenterol 2021;27:7969-7981. https://doi.org/10.3748/wjg.v27.i46.7969.
Gabrielli M, Franza L, Esperide A, Gasparrini I, Gasbarrini A, Franceschi F, et al. Liver injury in patients hospitalized for covid-19: Possible role of therapy. Vaccines (Basel) 2022;10:192. https://doi.org/10.3390/vaccines10020192.
Díaz LA, Idalsoaga F, Cannistra M, Candia R, Cabrera D, Barrera F, et al. High prevalence of hepatic steatosis and vascular thrombosis in COVID-19: A systematic review and meta-analysis of autopsy data. World J Gastroenterol 2020;26:7693-7706. https://doi.org/10.3748/wjg.v26.i48.7693.
Kovalic AJ, Satapathy SK, Thuluvath PJ. Prevalence of chronic liver disease in patients with COVID-19 and their clinical outcomes: a systematic review and meta-analysis. Hepatol Int 2020;14:612-620. https://doi.org/10.1007/s12072-020-10078-2.
Singh S, Khan A. Clinical characteristics and outcomes of coronavirus disease 2019 among patients with preexisting liver disease in the United States: A multicenter research network study. Gastroenterology 2020;159:768-771.e763. https://doi.org/10.1053/j.gastro.2020.04.064.
Iavarone M, D'Ambrosio R, Soria A, Triolo M, Pugliese N, Del Poggio P, et al. High rates of 30-day mortality in patients with cirrhosis and COVID-19. J Hepatol 2020;73:1063-1071. https://doi.org/10.1016/j.jhep.2020.06.001.
Marjot T, Moon AM, Cook JA, Abd-Elsalam S, Aloman C, Armstrong MJ, et al. Outcomes following SARS-CoV-2 infection in patients with chronic liver disease: An international registry study. J Hepatol 2021;74:567-577. https://doi.org/10.1016/j.jhep.2020.09.024.
Boettler T, Marjot T, Newsome PN, Mondelli MU, Maticic M, Cordero E, et al. Impact of COVID-19 on the care of patients with liver disease: EASL-ESCMID position paper after 6 months of the pandemic. JHEP Rep 2020;2:100169. https://doi.org/10.1016/j.jhepr.2020.100169.
Anirvan P, Singh SP, Giammarino A, Satapathy SK. Association of non-alcoholic fatty liver disease and COVID-19: A literature review of current evidence. World J Hepatol 2021;13:916-925. https://doi.org/10.4254/wjh.v13.i8.916.
Zheng KI, Gao F, Wang XB, Sun QF, Pan KH, Wang TY, et al. Letter to the Editor: Obesity as a risk factor for greater severity of COVID-19 in patients with metabolic associated fatty liver disease. Metabolism 2020;108:154244. https://doi.org/10.1016/j.metabol.2020.154244.
Holly JMP, Biernacka K, Maskell N, Perks CM. Obesity, diabetes and COVID-19: An infectious disease spreading from the east collides with the consequences of an unhealthy western lifestyle. Front Endocrinol 2020;11:582870. https://doi.org/10.3389/fendo.2020.582870.
Hu X, Sun L, Guo Z, Wu C, Yu X, Li J. Management of COVID-19 patients with chronic liver diseases and liver transplants. Ann Hepatol 2022;27:100653. https://doi.org/10.1016/j.aohep.2021.100653.
Gaspar R, Castelo-Branco C, Macedo G. Liver and COVID-19: From care of patients with liver diseases to liver injury. World J Hepatol 2021;13:1367-1377. https://doi.org/10.4254/wjh.v13.i10.1367.
Ekpanyapong S, Bunchorntavakul C, Reddy KR. COVID-19 and the liver: lessons learnt from the EAST and the WEST, a year later. J Viral Hepat 2022;29:4-20. https://doi.org/10.1111/jvh.13590.
Du M, Yang S, Liu M, Liu J. COVID-19 and liver dysfunction: Epidemiology, association and potential mechanisms. Clin Res Hepatol Gastroenterol 2022;46:101793. https://doi.org/10.1016/j.clinre.2021.101793.
Harapan H, Fajar JK, Supriono S, Soegiarto G, Wulandari L, Seratin F, et al. The prevalence, predictors and outcomes of acute liver injury among patients with COVID-19: A systematic review and meta-analysis. Rev Med Virol 2021:e2304. https://doi.org/10.1002/rmv.2304.
Chan SL, Kudo M. Impacts of COVID-19 on liver cancers: During and after the pandemic. Liver Cancer 2020;9:491-502. https://doi.org/10.1159/000510765.
Alfishawy M, Nso N, Nassar M, Ariyaratnam J, Bhuiyan S, Siddiqui RS, et al. Liver transplantation during global COVID-19 pandemic. World J Clin Cases 2021;9:6608-6623. https://doi.org/10.12998/wjcc.v9.i23.6608.
Nickerson AM, Sobotka LA, Kelly SG. PRO: liver transplantation in the times of COVID-19: "To transplant or not to transplant". Clin Liver Dis (Hoboken) 2021;18:230-232. https://doi.org/10.1002/cld.1131.
Kulkarni AV, Tevethia HV, Premkumar M, Arab JP, Candia R, Kumar K, et al. Impact of COVID-19 on liver transplant recipients-A systematic review and meta-analysis. EClinicalMedicine 2021;38:101025. https://doi.org/10.1016/j.eclinm.2021.101025.
Webb GJ, Marjot T, Cook JA, Aloman C, Armstrong MJ, Brenner EJ, et al. Outcomes following SARS-CoV-2 infection in liver transplant recipients: an international registry study. Lancet Gastroenterol Hepatol 2020;5:1008-1016. https://doi.org/10.1016/s2468-1253(20)30271-5.
Becchetti C, Gschwend SG, Dufour J-F, Banz V. COVID-19 in liver transplant recipients: A systematic review. J Clin Med 2021;10:4015. https://doi.org/10.3390/jcm10174015.
Al-Ali D, Elshafeey A, Mushannen M, Kawas H, Shafiq A, Mhaimeed N, et al. Cardiovascular and haematological events post COVID-19 vaccination: A systematic review. J Cell Mol Med 2022;26:636-653. https://doi.org/10.1111/jcmm.17137.
Global Hepatology Society Statement. Vaccination for SARS-CoV-2 in patients with liver disease. 2021. Acceso 11 de mayo de 2022. Disponible en https://www.aasld.org/sites/default/files/2021-05/Joint%20Society%20Statement%20-%20COVID-19%20Vaccination%20May%202021.pdf?fbclid=IwAR3TTUuwTpmHVernEZj8oBDRja0Le7qbpPmIt4JUQi1pwguR8Un3JYCj0wk.
Salinas MA, Arias YR, Plazas-Sierra DC. Lineamiento técnico para la Red de Donación y Trasplantes relacionado con el coronavirus SARS-CoV-2, responsable de ocasionar la enfermedad infecciosa por coronavirus (COVID-19). Bogotá D.C.: Instituto Nacional de Salud (INS); 2022. Acceso 19 de mayo de 2022.
Descargas
Publicado
Cómo citar
Número
Sección
Licencia
Esta obra está bajo una licencia internacional Creative Commons Atribución-NoComercial-SinDerivadas 4.0.
La política de reconocimiento de autoría de Hepatología se basa en los criterios indicados por el ICMJE para conferir crédito de un trabajo a una persona, a la vez que se le atribuye responsabilidad por la publicación del mismo.
